Clinical Trials Directory

Trials / Conditions / Pseudomonas Infections

Pseudomonas Infections

11 registered clinical trials studyying Pseudomonas Infections — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingMonotherapy vs Combination Therapy for Bone Infections Caused by Pseudomonas Aeruginosa
NCT07056881
Centre Hospitalier de Saint-Denis—
RecruitingAntimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa
NCT06738771
Centre Hospitalier Régional d'Orléans—
UnknownTobramycin in Bronchiectasis Colonized With Pseudmonas Aeruginosa
NCT03715322
Guangzhou Institute of Respiratory DiseasePhase 3
CompletedSafety and Efficacy Study of Ftortiazinon in the Treatment of Patients With Complicated Urinary Tract Infectio
NCT03638830
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian FederationPhase 2
UnknownClinical Outcomes With Ceftolozane-tazobactam for MDR Pseudomonas Infections
NCT03510351
Temple University—
RecruitingMonocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis
NCT03044223
University of Ulm—
CompletedOptimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 1
NCT00235690
University of PittsburghN/A
CompletedPharmacokinetic Evaluation of an 8 -Week Treatment With Inhaled Tobramycin
NCT00634192
NovartisPhase 3
TerminatedAzithromycin as a Quorum-Sensing Inhibitor for the Prevention of Pseudomonas Aeruginosa Ventilator-Associated
NCT00610623
Anbics Management-Services AgPhase 2
TerminatedLcr35 / ICU / P. Aeruginosa
NCT00621803
University Hospital, Clermont-FerrandN/A
CompletedBenefits and Risks of Newborn Screening for Cystic Fibrosis
NCT00014950
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)N/A